XTNT — Xtant Medical Holdings, Inc.
—
NYSE ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1453593 ·
Last close
$0.36
Market Cap
$49.91M
52W High
$0.95
52W Low
$0.27
ADV30
3,448,455
Next earnings
2026-11-10
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 23,031,000 | 13,330,000 | -4,169,000 | -9,413,000 | 79,667,000 | 9,870,000 | 39,652,000 |
| Mar 2026 | 20,884,000 | 11,971,000 | -2,923,000 | -3,089,000 | 78,000,000 | 12,137,000 | 29,401,000 |
| Dec 2025 | 32,357,000 | 17,754,000 | -944,000 | 57,000 | 94,145,000 | 17,053,000 | 43,192,000 |
| Sep 2025 | 33,255,000 | 21,992,000 | 2,541,000 | 1,308,000 | 106,321,000 | 10,400,000 | 55,938,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$9,154,000
Investing CF
$19,262,000
Financing CF
$-21,926,000
CapEx
$-1,385,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.01
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-257,575,000
Inventory
$31,881,000
Receivables
$17,179,000
ST Investments
—
EBIT TTM
$7,131,000
Pretax Income TTM
$3,906,000
Interest Exp TTM
$3,225,000
Analysts
2
Yahoo Snapshot (yfinance, live)
Total Revenue
$109,527,000
EBITDA
$-1,473,000
Free Cash Flow
$10,128,750
Enterprise Value
$64,653,576
Total Cash
$9,870,000
Total Debt
$26,012,000
Shares Out
140,287,960
Trailing EPS
$-0.08
Book Value
$0.28
ROE
-25.2%
ROA
-3.8%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 133,927,000 | 7,284,000 | 4,973,000 | 94,145,000 | 43,192,000 | 50,953,000 | 12,546,000 |
| Dec 2024 | 117,267,000 | -12,074,000 | -16,449,000 | 93,837,000 | 50,874,000 | 42,963,000 | -11,896,000 |
| Dec 2023 | 91,303,000 | -10,158,000 | 660,000 | 92,612,000 | 41,263,000 | 51,349,000 | -9,515,000 |
| Dec 2022 | 57,969,000 | -6,755,000 | -8,485,000 | 60,229,000 | 26,058,000 | 34,171,000 | -5,341,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.03
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| NNOX | Nano-X Imaging Ltd. | $49.68M | $0.63 | — |
| POCI | PRECISION OPTICS CORPORATION, INC. | $49.53M | $4.53 | — |
| SRTS | Sensus Healthcare, Inc. | $49.30M | $2.99 | — |
| VASO | VASO Corp | $51.05M | $0.29 | — |
| APT | ALPHA PRO TECH LTD | $51.44M | $5.04 | — |
News headlines (Yahoo Finance, 1h cache)
Xtant Medical Holdings Inc (XTNT) (Q2 2026) Earnings Call Highlights: Strategic Expansion Amid ...
2026-08-11 21:02 · Yahoo
Xtant Medical to Participate in the Canaccord Genuity 46th Annual Growth Conference
2026-08-04 20:05 · Yahoo
Xtant Medical Holdings Inc (XTNT) Q1 2026 Earnings Call Highlights: Navigating Challenges and ...
2026-05-13 23:01 · Yahoo
Xtant Medical Holdings, Inc. Q1 2026 Earnings Call Summary
2026-05-14 00:39 · Yahoo
Xtant Medical to Announce First Quarter 2026 Financial Results on May 13, 2026
2026-05-07 12:00 · Yahoo
Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped
2026-05-06 12:00 · Yahoo
Xtant Medical Holdings Inc (XTNT) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...
2026-03-31 19:01 · Yahoo
Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product
2026-04-13 13:04 · Yahoo
Xtant Medical Holdings, Inc. Q4 2025 Earnings Call Summary
2026-03-31 16:47 · Yahoo
Xtant Medical Announces Exclusive Partnership with BioHorizons to Expand Access to Xtant's Allogeneic Growth Factor into the Dental Market
2026-08-27 12:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.